Tumor-specific CD4+ T cells have a major 'post-licensing' role in CTL mediated anti-tumor immunity

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6047-6055

  Marzo, A L ^a   Kinnear, B F ^a   Lake, R A ^a   Frelinger, J J ^a   Collins, E J ^a   Robinson, B W S ^a   Scott, B ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; INTERFERON PRODUCTION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0034541167     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6047     Document Type: Article

References (33)

1. + tumor-infiltrating lymphocytes in human solid tumors
2. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
3. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
4. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
5. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
6. + T-helper and a T-killer cell
7. + T cells
8. Viral immune evasion due to persistence of activated T cells without effector function
9. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity
10. + T cell-mediated spontaneous diabetes in neonatal mice
11. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
12. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors
13. Establishment of a murine model of malignant mesothelioma
14. + T cells
15. Differentiation of naive CTL to effector and memory CTL: Correlation of effector function with phenotype and cell division
16. HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides
17. Ligand recognition by α-β T cell receptors
18. + T cells using an ELISPOT assay
19. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
20. Patho- and immunobiology of malignant mesothelioma: Characterisation of tumor infiltrating T leukocytes and cytokine production in a murine model
21. Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides
22. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-l/Melan A
23. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy
24. Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: Normal development but restrained effector function in vivo
25. Tumor antigens are constitutively presented in the draining lymph nodes
26. + cytotoxic T-cell responses during chronic viral infection
27. + T cell help
28. Enhancement of antitumor immunity by CTLA-4 blockade
29. + T helper cell function in vivo: Differential requirement for induction of antiviral cytotoxic T-cell and antibody responses
30. + cells but markedly decreased helper cell activity in mice lacking CD4
31. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice
32. CTL access to tissue antigen is restricted in vivo
33. + T cells in the antitumor immune response